Rayner announced its direct entry into the French cataract and refractive market. Based out of Lille in the Hauts-de-France region, Rayner has a growing team of ophthalmic specialist area managers focused on delivering service and support.
Through this team, French ophthalmologists now have access to the Rayner portfolio, including RayOne fully preloaded and Sulcoflex supplementary IOLs; the AEON family of dry eye drops; and their proprietary RayPRO digital platform that collects patient reported outcomes over 3 years.
“I would like to warmly welcome Rayner to France. It’s a wonderful opportunity to directly work with the company who manufactured the world's first IOL, the Sulcoflex add-on IOL, and the RayOne preloaded portfolio because closer access to Rayner’s latest technologies will make for more effective exchange of ideas and information,” Dr. Alain Saad, Rothschild Foundation Hospital, Paris, said in a company news release.
With the second largest population in Western Europe and 13.3 IOL surgeries per thousand, France is strategically important to achieving Rayner’s goal of being direct in all major European markets, Rayner stated in the news release.
More than 5 million IOL surgeries will be performed in 2022 across Western Europe, and following Rayner’s previous entries into DACH, Iberia, and Italy, 80% of this market can now be served directly by local Rayner subsidiaries, with full access to Rayner’s latest technologies.
“We are delighted to expand into France and develop our relationships with some of the most important groups and surgeons in Europe," Rayner Vice President Europe James Crutchlow said in the news release. "The ability to directly engage with French ophthalmologists in the research and development of new innovations will ensure we better serve the market with the next generation of ophthalmic solutions. We are excited to see country manager, Philippe Alix, and his team increase our footprint in France.”